Digital health innovations
We are actively seeking proven digital innovations that improve the health of people in the region and raise the quality, efficiency, safety and cost-effectiveness of delivering healthcare.
We are particularly interested to hear about innovations in the following categories:
  • Health maintenance - supporting people in maintaining their physical and mental wellbeing,
  • Prevention - alerting patients, carers or professionals when there are signs that things aren’t going well, and an intervention can prevent crises or emergencies
  • Access - providing more convenient and cost-effective ways for patients and professionals to interact. (e.g. remote monitoring or virtual consultations).
  • Learning and education - delivering information and knowledge to patients about their health or condition, or to professionals to support their continuous professional development
  • Pathways - providing tailored information to patients, carers and professionals on services to signpost people to the most appropriate place.  Ideally, this could be enhanced with real-time information about capacity.
  • Research - using digital tools to promote involvement in research & clinical trials, to streamline the capture of informed consent, and to capture research data more efficiently and conveniently.
  • Integration - tools that enable the secure, appropriate sharing of information between organisations (e.g. GPs and hospital clinicians) and sectors (e.g. NHS and Social Services) to allow patients to receive seamless care.
  • Data Visualisation - innovative ways of presenting information in a meaningful way to enable more informed decisions by patients and professionals.  This may involve aggregating data from different sources, reporting tools or graphic visualisations such as heat maps.

Ideas (Publish, Detailed Submission)

Innovation 'Elevator Pitch':
Optifit is the first clinically validated therapeutic bra and fitting system, promoting a balanced posture, reducing musculoskeletal health problems associated with larger bust sizes. Optifit provides a proven alternative to breast reduction surgery
Overview of Innovation:
The OptiFit bra and measurement system, designed by a Consultant Plastic & Reconstructive surgeon with bespoke manufacturing in the UK. www.optifitbra.com
  • Ensures an effective and comfortable ‘bespoke’ fit
  • Significantly reduces trauma and pain in Thoracic and Lumbosacral regions
  • Prevents overstretching of the suspensory ligament reducing the chance of stretch marks.
  • Preserves body shape
  • Maintains healthy posture, relieving pressure on diaphragm and balance pelvis
  • Reduces risks of tissue maceration, intertrigo and fungal growth
It is estimated that 70% of women wear the wrong size bra. The traditional alphabet bra size measurement system was initially only established for cup sizes A-D, but with 40% of British females measuring a D cup or above the same level of fit and support is not achieved in larger sizes. Failure to support the breasts can lead to many physiological conditions including back and breast pain.
 
Inappropriately sized and positioned back straps cause existing bras to slide away from the breasts reducing support. It is estimated that 70% of women wear poorly fitting bras and that 99% of women with large breasts wear the wrong size bra.  Professionally fitted bras are often as poorly fitted as ‘off the shelf products.
 
Bras that do not support the breast correctly cause many skin problems. If the weight of the breasts is mostly supported by the shoulder straps, these can dig in and cause angry red welts to develop.
Underwired bras push into the tissue leading to lesions, marks and sores.
Optifit bras do not use underwires. They hold the breast in its natural position away from the body preventing the above problems.
If the breasts are not supported away from the ribs, rubbed skin, maceration, intertrigo and fungal infections can develop underneath.
 
what_is-1.png     what_is-2.png     
 
Summary of interim research study findings -
  • Can help patients with Back pain
  • Can obviate need for breast reduction surgery in many patients
  • Is a cure for Inframammary intertrigo
Can potentially help patients with mastalgia especially those with associated shoulder girdle dysfunction
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Wealth creation / Clinical trials and evidence / Innovation and adoption / Person centred care
Benefit to NHS:
How best to allocate surgical resources and time within the NHS is a problem with which we wrestle and disagree constantly. Reduction mammaplasty is surgery rationed in NHS practice, yet evidence suggests that those who undergo it derive significant improvements in physical health and quality of life.
 
NHS recommends professionally fitted bras prior to Breast reduction surgery but has not evaluated their efficacy.
 
Many women do not fulfill the criteria for surgery e.g. high BMI.  Such patients have nowhere to go and are a burden on the NHS, requiring drugs for back pain, intertrigo etc. Furthermore, women with high BMI’s cannot find a properly fitted bra. The Optifit bra will help such patients and overall reduce the need for breast reduction surgery. Women seeking reduction mammaplasty often wear ill-fitting bras and are therefore likely to exacerbate some of their presenting symptoms as a result. Women may wait years from referral to surgery and symptom relief. A correctly fitted bra alleviates symptoms and may even remove the need or wish for surgery.

Savings from reduced surgical intervention and associated consultations, imaging and follow ups will be enormous, (‘21,328 procedures were carried out between 2006 and 2011, some on girls as young as 15 -which, at £5,000 each, cost taxpayers more than £106 million’. (Daily Mail July 2014)).
 
Back Pain: OptiFit should be a 1st line treatment for LBP in women with high BMI’s and/or large breasts.  A systematic review on global prevalence of LBP the highest prevalence showed women aged between 40-80 (incidence 11.9%  http://www.ncbi.nlm.nih.gov/pubmed/22231424). The OptiFit intervention would help many patients and demonstrate significant savings for the NHS
 
Intertrigo: A direct result of friction between two skin surfaces. With poorly fitted bras there is a mismatch between cup/cradle diameter and breast base.  Patients I see regularly in my clinic have had several ‘Professional’ fittings and still cannot find the correct size bra. With it’s unique design the Optifit bra remains in the inframammary crease (however large the breast and BMI may be) and it is therefore impossible to get intertrigo
 
Mastalgia: Incidence of mastalgia in the general population is reported as over 60% http://www.ncbi.nlm.nih.gov/pubmed/9240595  Most women who attend Breast Clinics with breast pain also have musculoskeletal pain related to breast size.  The 1st line of treatment for mastalgia is a professionally fitted bra
Initial Review Rating
2.60 (1 ratings)
Benefit to WM population:
The savings resulting from reduced surgical intervention and the associated consultations, imaging and follow up will be enormous, (‘21,328 procedures were carried out between 2006 and 2011, some on girls as young as 15 - which, at £5,000 each, cost taxpayers more than £106 million’. (Daily Mail July 2014)). In addition the benefits in QALY outcome measures for women will also be substantial.
 
Back Pain: We feel that this product should be recommended as a first line treatment for low back pain in women with high BMI’s and/or large breasts.  In a systematic review on the global prevalence of the low back pain in the world the highest prevalence was noted to be in women between the age of 40-80.  The incidence was found to be 11.9%  http://www.ncbi.nlm.nih.gov/pubmed/22231424 .. This simple intervention should help many patient and save the NHS on many interventions.
 
Inframammary Intertrigo:It is difficult to comment on the incidence of inframmary intertrigo in the general population as there is not ICD-10 or ICPC score.   Intertrigo is a direct result of friction between two skin surfaces.  This is due to a poorly fitted bra as there is a mismatch between the cup/cradle diameter and the breast base ( the breast base in patients with high BMIs can be several centimetres more than the cup/cradle diameter in professionally fitted bras).  The patients I see regularly in my clinic with intertrigo have had several fittings and still cannot find the correct size bra as it simply does not exist for them. With its’ unique design the optifit bra, however, stays at the inframammary crease( however large the breast and BMI may be) and it is simply not possible to get intertrigo.
 
Mastalgia: The incidence of mastalgia in the general population has been noted in studies to be over 60%.  http://www.ncbi.nlm.nih.gov/pubmed/9240595 .   Most women who attend Breast Clinics with breast pain also have musculoskeletal pain related to breast size.  The first line of treatment for mastalgia is a professionally fitted bra.
Current and planned activity: 
Ongoing research studies at University of Central Lancashire:
  • Exploring the OptiFit bra solution against fashion industry standards
  •  To determine the initial and short term biomechanical effects on posture when wearing the OptiFit bra compared to the standard or usual bra, in individuals with back or neck pain.
  • To determine the initial and short term effects on breast health, pain, activity and comfort when wearing the OptiFit bra compared to the standard or usual bra, in individuals with back or neck pain 
Required studies:
  • A community based study of incidence of inframammary intertrigo in general population resulting from poor bra fitting
  • A comparative efficacy study is required for surgical and non surgical management of symptomatic macromastia
  • Health Economics cost benefits analysis of surgical vs non surgical intervention
Further trial partners required to evaluate the product and measurement system
What is the intellectual property status of your innovation?:
Patent for Bra (GB2362560B): The granted patent has four independent claims. These are (claim 1) which covers the bra itself,  (claim 7) which covers a method of fitting a bra according to the invention, (claim 10) which covers a range of bras according to your invention and (claims 11 and 12) which cover a bra and method of making a bra respectively with particular emphasis on the back portions.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Atul Khanna 29/04/2016 - 12:18 Publish 2 comments
5.7
3
Votes
-99999
Innovation 'Elevator Pitch':
ExerSciz Solutions is an on-line tool that creates individualised exercise programs for risk reduction, disease treatment and overall improved health for patients with Long Term Conditions.
Overview of Innovation:
ExerSciz Solutions utilises the latest in exercise and scientific literature to develop programs that are specific to an individual’s physiology, health condition and goals, level of exercise, time available and individual choice of cardiovascular training.
Patients, supported by clinicians, can select from a number of goals. These include weight loss, with or without calorie restriction, risk reduction and treatment of heart disease and stroke, diabetes, metabolic syndrome, arthritis, osteoporosis, balanced health and many other health based goals.
The programs adapt to the availability of various exercise equipment. Programs can be designed for those without any equipment. The programs can be done at home, in the gym, or wherever an individual chooses. The programs will progress week to week and month to month as long as an individual is doing approximately 70% of his or her workouts. The cardiovascular portion of the program gives clients their specific exercise zones to work out in. The exercise zones are unique to each individual's particular health needs as well as body physiology.  By using both screening tools and perceived exertion, the programs are safer than a patient choosing to exercise on his or her own. Since most individuals have smart phones today, an ExerSciz program is just like having a personal exercise trainer in the client's pocket at all times.
Patients are able to perform an assessment using their smart phone in order to give them an ExerSciz Fitness index ("EFI") rating.  The EFI is a proprietary exercise score that compares each client to age adjusted norms and allows each client to benchmark their current status, as well as monitor progress. In addition, patients are able to track their activity on the website, giving them both activity scores and health scores.  We will soon have the ability to automatically track this if the client is using a wearable device that is compatible with the ExerSciz program.
Patients and doctors will be able to see the results and appreciate that they are “Exercising smarter, not harder” as their program is literally putting exercise based science into their unique personalised exercise experience, promoting their health and wellbeing. 
An individualised ExerSciz program will be complementary to any ongoing health or medical intervention, initiative and treatment a patient may be involved in and should reduce health costs, as well as help develop ownership of their own health.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Wealth creation / Clinical trials and evidence / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
  • Cost saving benefits as a result of better disease prevention, health promotion, disease treatment, rehabilitation and ongoing maintenance of health and function.
  • Time spent in physiotherapy and follow up appointments is better spent, as exercise can also  be conducted safely in an unsupervised manner and/or at home
  • Clinicians can monitor the progress of patients who exercise, resulting in the formulation of enhanced treatment plans.
  • ExerSciz Programs aid in the development of the patient’s ownership and control of his or her own health objectives.
  • ExerSciz can help to maintain an individual’s health, prevent the deterioration of disease, allow convenient and cost effective access to exercise expertise and can help to educate patients about the best exercise for their condition.
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
ExerSciz Solutions directly fits into the Digital health innovations campaign and could also assist with the diabetes campaign. Our app can help to maintain an individual’s health, prevent the deterioration of disease, allow convenient and cost effective access to exercise expertise and can help to education patients about the best exercise for their condition. Ultimately saving the NHS within the region money and avoidable admissions.
In addition the benefit ExerSciz Solutions can have on multiple long term conditions would directly benefit the West Midlands region.  
The most common reason individuals give for starting an exercise program is to lose weight, however most individuals, do not know where to start, are afraid they may hurt themselves and for a variety of reasons, will not join a gym. Many individuals, wanting to lose weight, often exercise too hard, in a zone that is less effective for weight loss and more prone to injury. These individuals frequently do not lose weight, often get frustrated and stop exercising.  Access to this tool, as part of a larger health campaign, will give individuals enough trust in the site to at least initiate and try a program. The ExerSciz application will enable an individual to exercise with or without calorie restriction in a safe and effective manner, using exercise zones that are specific to body fat loss, as well as an included nutritional recommendation tool to complement this.
Exercise has been shown repeatedly in scientific studies to have significant overall health benefits as well as increased productivity and enjoyment of life. Even a small percentage change in non-exercisers to exercise adopters could have significant socio/health-economic benefits to the region.
Current and planned activity: 
Current activity:
Digital Health Solutions is actively seeking NHS partnerships to engage with ExerSciz Solutions. The app has been developed and evaluated within Canada and USA and a collaboration within the UK is currently being sought as the product is successfully being marketed and used with Canada and the US.

Planned activity:
  • Procurement / Adoption of ExerSciz Solutions by West Midlands NHS Trusts
  • Evaluation of the app and its potential wide scale usage across the region and the wider NHS
  • Support with Information Governance, N3 connectivity and data capture to aid further growth and development within the NHS
What is the intellectual property status of your innovation?:
All intellectual property is owned by ExerSciz Solutions Inc. in US and Digital Health Solutions Ltd in the UK and Europe
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
Simple
Read more
Hide details
Andrew Lane 27/04/2016 - 17:21 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
e-ASPECTS automates medical imaging analysis, providing confident decisions in the treatment pathway for acute stroke patients.  e-ASPECTS automatically implements the clinical scoring methodology, Alberta Stroke Programme Early CT.
Overview of Innovation:
Brainomix’s ground-breaking technology, e-ASPECTS, circumnavigates the time lag to treatment by automatically implementing the Alberta Stroke Programme Early CT Score (ASPECTS) scoring system on brain images from acute ischemic stroke patients, to identify and quantify signs of early ischemic stroke damage and provide an assessment to support treatment decisions.

Innovation of Brainomix e-ASPECTS Stroke Imaging
The key thing to note that is that the solution is highly innovative and first to market of its kind with no comparable solution available. Our co-founders include Professor Alastair Buchan, dean of medicine at Oxford University and the inventor of the ASPECTS score, and practicing clinician Professor Iris Grunwald, interventional Neuroradiologist at Southend Hospital and one of the first physicians to be successfully performing thrombectomies in the UK. 
  • e-ASPECTS is a decision support tool that automates the clinically validates ASPECT method scoring of CT scans, providing a fast, standardized result
  • e-ASPECTS is the only decision support tool for scoring non-contrast CT scans of stroke patients using the ASPECT method - a well established stroke scoring system
  • It is CE marked and has been validated to perform as well as expert Neuroradiologists in performing ASPECTS on hyper-acute stroke patient scans
  • Multiple randomized multicentre clinical trials have demonstrated (as recently as last year) that endovascular treatment is effective, and it is set to become the future standard of stroke care (in conjunction with existing thrombolysis treatments).
  • International guidelines for the selection of patients for this treatment include the ASPECTS score for identifying ischaemic core on non-contrast CT scans
 Health Economics
·         Reduced length of stay – baseline 0.04 days per patient
·         Identifies the correct treatment option for stroke patients and speeds up
          treatment times
·         Reduced decision making time for stroke patient – baseline 15 minutes per
          patient
·         Increased uptake of thrombectomy - baseline x 1.1 (i.e. 10% increase)
·         Cost savings - projected cost saving for a 15 minute time reduction in
          decision making is £40 of consultant time, plus £21 from reduced length of
          stay, leading to a total of £61 saving per patient. If thrombolysis uptake is               also increased by 20%, the total saving rises to £150 per patient.


 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Advanced diagnostics, genomics and precision medicine / Digital health
Benefit to NHS:
Health Economics
·         Reduced length of stay – baseline 0.04 days per patient
·         Identifies the correct treatment option for stroke patients and speeds up treatment times
·         Reduced decision making time for stroke patient – baseline 15 minutes per patient
·         Increased uptake of thrombectomy - baseline x 1.1 (i.e. 10% increase)
·         Cost savings - projected cost saving for a 15 minute time reduction in decision making is £40 of consultant time,
          plus £21 from reduced length of stay, leading to a total of £61 saving per patient. If thrombolysis uptake is also
          increased by 20%, the total saving rises to £150 per patient.
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
Better patient outcomes and treatment options.
Current and planned activity: 
We already have a number of NHS Hospitals and hospitals abroad using this solution. Once we have engaged with a Clinician who is interested in this solution we arrange to provide them with a demonstration so they understand the full benefits of the technology.
What is the intellectual property status of your innovation?:
IP is wholly owned by Brainomix. We follow a "trade secret" approach rather than patenting as we believe that this is more appropriate as it is a software device.
 
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
Simple
Regulatory Approvals:
Please describe any current regulatory approvals you have achieved and how they were met/ in progress/planned.
Commercial information:
Please describe how the product/service is being developed commercially, whether in development, trials, pilot or full commercial delivery. Include the results you have from any market/demand surveys and forecasts . Please include any research you have on the broader commercial opportunity for the innovation both within the health sector nationally and internationally.
Investment activity:
Please describe what stage of investment you have reached and whether you are seeking additional rounds of investment. Please include cash investment as well as investment of soft assets such as access to specialist equipment, knowledge, trial base etc. and indicate the types/sources of your investment such as grants etc.
Regional Scalability:
Please describe how the innovation could be scaled across the WM region. Have you implemented at scale in any other regions?
Measures:
What outcomes are you hoping to achieve and what are the measures that you will use to gauge the success of the innovation and how will these assessments be made? Please ensure that you have quality, safety, cost and people measures.
Adoption target:
What are the targets for adoption across the WM and what are the minimum viability levels?
Investment sought:
What investment are you looking for in order to support wider adoption of this innovation and what have you managed to secure to date? Please provide a breakdown of these costs if possible.
Read more
Hide details
Deb Whitehall 26/04/2016 - 18:26 Publish Login or Register to post comments
6
1
Votes
-99999
Innovation 'Elevator Pitch':
The Amplitude pro enterprise™ uses simple technology to allow clinicians & healthcare professionals to collect clinical outcomes and use them to measure a reduction in patient symptoms and an improvement in quality of life.
Overview of Innovation:
The Amplitude pro™ series is a new way of capturing and managing PROMS. 

All hospitals strive to continuously improve levels of patient care. In order to monitor the services you provide to your patients, you must measure what you do and how you do it. pro enterprise™ combines clinical outcomes and patient experience evaluations by utilising efficient, cost effective, web based software. The resulting information gives you an accurate insight into the performance of your hospital and the knowledge required to devise strategies to achieve continuous improvement.
The pro enterprise™ software is a simple, tailored online platform centred around two crucial elements, helping you to achieve a more personalised way of patient monitoring:
  • A user-friendly electronic patient portal which gives patients the freedom of completing their scores online at home, on site and via various hardware.
  • A consultant dashboard that gives your clinicians the ability to input patient specific complexity factors and procedure data quickly and easily.
The result is representative, accurate and meaningful data that paints a clearer picture of each patient’s level of health and expected recovery. Your clinicians are engaged with clinical outcomes processes at your hospital, you get the insight you need to better manage your hospital services and patients get a consistently high standard level of care.
pro enterprise™ is the first product to give an accurate, ‘whole picture’ view of your hospital’s performance. It is simple, cost effective and delivers precise and accurate data, selecting scores that are identified as important to you.
The data you collect in pro enterprise™ will allow you to monitor your service delivery, identify quality issues and demonstrate levels of care. Your hospital can be confidently transparent about its activities, resulting in reassurance to your community that you are offering the best care possible.
pro enterprise™ is available across all specialties and can be customised according to the needs of you and your clinicians. The system is quick, user friendly and mostly automated. By sending out the appropriate scores at pre-defined intervals, it seeks patient interaction electronically and automatically prompts patients to respond at key stages along the clinical pathway. Clinical information can be added using time saving custom defaults whereby the clinician can add data and the data collected is relevant and clinically validated.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Digital health / Innovation and adoption
Benefit to NHS:
pro enterprise™ will interface with other hospital systems to capture demographic data, avoiding duplication and achieving staff acceptance and compliance. It can also run independently if that is your preference. pro enterprise™ abides by strict NHS Information Governance guidelines, Data Protection policies and has been penetration tested. Amplitude can host your system on its secure N3 server or you can choose to host the system internally. Amplitude offers additional services and guidance around patient engagement and communications to ensure that you have all of the skills and tools that you need to create a highly compliant, positive outcomes culture in your hospital.
Initial Review Rating
3.40 (1 ratings)
Benefit to WM population:
A coherent reporting system can be achieved by utilising Amplitude across the West Midlands Trusts. The reporting system would allow for a joined up report displaying results across individual hospitals and trusts, as well as over the region as a whole. The ease at which the results can be obtained and displayed should increase the engagement of both patients and clinicians across the West Midlands area.
Our innovation does not only benefit people of the West Midlands, but worldwide.
All information is supplied by patients and validated by clinicians, ensuring it is meaningful and representative and provides a rich picture of your individual healthcare experience.
Amplitude Clinical Outcomes is accredited by the Private Healthcare Information Network (PHIN) to collect outcomes data for the UK private healthcare sector.  This is in line with the requirements of the Competition and Markets Authority.
Current and planned activity: 
Amplitude pro enterprise™ is currently in a number of NHS Trusts. Please see below for examples of these trusts and the departments that are using the system:
 
Abertawe Bro Morgannwg University Health Board (Swansea) – All subspecialties
Aintree University Hospitals NHS Foundation Trust (Liverpool) – Foot & Ankle and Knee
Royal Orthopaedic Hospital (Birmingham) – Hip & Knee
Cardiff and Vale University Health Board (Cardiff) – Hip & Knee
Royal National Orthopaedic Hospital (London) – All subspecialties
Glasgow Royal Infirmary (Glasgow) - Shoulders
University Hospital Coventry (Coventry) – Department yet to be decided
Royal Berkshire Hospital NHS Foundation Trust (Reading) – Department yet to be decided

Amplitude is seeking support to further increase the adoption of pro enterprise™ within all trusts in the West Midlands and raise the awareness of pro enterprise™ software and the multiple uses for hospitals and trusts.
 
What is the intellectual property status of your innovation?:
Amplitude Clinical Services holds all intellectual property for the system code and integrity.
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
2 years
Ease of scalability: 
2
Read more
Hide details
Emily Burnett 25/04/2016 - 12:56 Publish Login or Register to post comments
0
0
Votes
-99999
Innovation 'Elevator Pitch':
DLS Access gives patients same-day access to their healthcare professionals via the web/smartphone/Skype or telephone achieving savings of £15 per patient with additional benefits.
Overview of Innovation:
DLS Access allows healthcare professionals to deal with increasing patient demand more efficiently and delivers a clear return on investment.  DLS Access is a cloud based service which is purchased on an annual per patient licence basis across the whole patient population.  The service is backed-up with executive level support and access to a DLS Client Delivery Manager to ensure successful deployment into your organisation.
 
Consultation requests are made by registered patients using their phone, a smartphone app or via a web form.  All requests are directed in to the ‘Health Hub’ and handled by trained call centre operatives.
 
The Health Hub team puts each patient on a call-back list for the requested healthcare professional who then aims to call the patient back within an hour, either by phone or Skype, whichever the patient requested.  This system provides same day primary care access for the group’s patient population, without opening for extended hours.  Out of hours demand is managed better and patients are seen quicker.
 
Results from the first deployment of DLS Access, which was through their partnership with Modality (previously Vitality) Partnership in the Prime Minister’s Wave 1 Challenge Fund programme have been more than hoped for.
 
DLS Access has demonstrated a £15 saving per patient across the group.
  • Over 65% of all health concerns are now dealt with remotely, within the hour.
  • Practices within the group have seen between 5-10% reduction in A&E attendance as a result of the DLS Access Service.
  • The Group have seen a 72% reduction in missed GP and ANP appointments. 
Many other benefits have been seen across Modality’s business as well as a return on investment from the savings the DLS Access project has achieved, these are outlined in the ‘Benefit to the NHS’ section below.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Digital health / Person centred care
Benefit to NHS:
Results and benefits shown below have been tracked through Digital Life Sciences’ wave 1 Prime Minister’s Challenge Fund Programme, delivered in partnership with Modality (previously Vitality) Partnership between March 2013 and 2014.  The service continues to run, with the next steps of the digital strategy to be delivered through the Modality Vanguard programme.
 
The Modality Health Hub is one of the first truly digitally delivered primary care services and the first live example of how technology is enabling 65,000 patients to access their healthcare digitally.
 
DLS Access – Results for 65,000 patients
 
  • £15.49 saving per patient
  • 1600 patient hub contacts per day
  • 40 seconds average time calls are answered with in the Health Hub
  • 1,100 downloads of the Health Hub App to date
  • 400 website users per day
  • Over 4,000 registered online users
  • 68% of all health concerns are dealt with remotely within the hour
  • 32% of all patient demand now requires a face to face consultation
  • 72% reduction in missed GP and ANP appointments
  • Reduced consultation time – an average consultation is only 5 minutes, compared to the traditional 7 minute face to face consultation
  • Increased clinical capacity – early indications show up to a 10% increase in the number of patient consultations handled each day
  • Demand for appointments equalising – demand for appointments is equalising throughout the day and week, easing the historic 8am and Monday bottlenecks
  • Increasing online requests – an average of 50 online requests received per day with 28% received via the bespoke Android and iOS mobile apps 
“The new system is improving every day as patients and staff gets used to a different way of working.  Compared to the old system, I am able to speak to a greater number of patients per day and my patients only need to visit the surgery when absolutely necessary” – Dr Shaylor, Laurie Pike Health Centre
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
The return on investment calculations for a DLS One Patient Access PMCF Wave 1 project, based on 65,000 patients (costs are based on a transformed operating and workforce model that incurs no additional cost, which can be achieved with clear leadership and a commitment to change across the project.
 
Annual savings for patient population:
DNA’s based on 72% reduction £209,950.00
A&E attendance based on 18% reduction £1,186,900.00
Total annual savings for patient population £1,396,850.00
 
Cost to install One Patient Access:
One Patient Access model of £5 per patient per annum £390,000.00
 
Return on Investment (shown as savings):
Return on investment for whole patient population £1,006,850.00
Per patient ROI £15.49
 
Many other benefits can be realised such as reduced consultation time, increased clinical capacity, demand for appointments equalising and an increase in online requests.
 
More information is available – click here.
 
“Just a quick note to congratulate you on the Modality Partnership app.  Personally, I think this is a great app which has allowed me to connect very easily and quickly to my doctor” – Modality Patient (comment from Modality Partnership website.
Current and planned activity: 
DLS Access is currently being rolled out to 'at scale' primary care providers including the South Worcestershire GP Federation and Aylesbury Vale GPs. The business is actively engaged in selling the service across the NHS.
What is the intellectual property status of your innovation?:
The I.P. is wholly owned by Digital Life Sciences Ltd
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
1 year
Ease of scalability: 
2
Read more
Hide details
Robin Vickers 01/03/2016 - 15:23 Publish Login or Register to post comments
6
4
Votes
-99999
Innovation 'Elevator Pitch':
Whose Shoes?® is much more than a ‘board game’ or training. Through a range of scenarios and topics, Whose Shoes?® helps you explore the concerns, challenges and opportunities facing different groups affected by health and social care transformation
Overview of Innovation:
Whose Shoes? is a popular approach to co-production within the NHS, endorsed and actively supported by the Patient Experience team at NHS England and the Transformation team within NHS Improving Quality, as well as local authorities, universities and other public services. It is a flexible tool that can be adapted (through bespoke partnerships) to a wide range of topics and challenges. The original board game, launched in 2008, explored issues around the emerging personalisation agenda.
A person-centred and values-based focus remains central to all development.
New material is being developed through strong collaborations with passionate people, fired by a very strong social media presence and networking capability. Whose Shoes looks at issues from different perspectives and triggers crucial conversations, with real ‘light-bulb moments’ as participants come together as ‘people’ rather than roles and work together to find solutions to the issues that matter to them. Getting as wide a range of participants as possible around the table cuts across boundaries and flattens hierarchy.
The relaxed approach creates the conditions for ‘service users’ to contribute as equals in a relaxed environment which is conducive to open, honest exchanges. People are empowered to lead rather than simply contribute. There is a strong focus on action and sharing good practice widely, with participants encouraged to make pledges and to share good practice through stories and case studies and to promote these through social media. Graphic recording of Whose Shoes workshops is very popular with hospitals using the records as action plans.
The maternity version of Whose Shoes? has been developed in partnership with the London Strategic Clinical Network and NHS England. It was piloted in five London hospitals. Workshops are now spreading – including other London hospitals, Guernsey, Leeds, Cumbria and Manchester.
Whose Shoes? material to improve communications between children and young people, their parents and healthcare professionals has been co-produced with Great Ormond Street and HENCEL.
Scenarios to promote dementia-friendly communities and understanding by NHS staff of the challenges of living with dementia have been produced through partnerships with Skills for Health and an Age UK consortium. Integration scenarios are used in the Darzi programme. Bespoke scenarios around other areas of patient experience (e.g operating theatres) is being trialled with Kingston Hospital
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Wellness and prevention of illness / Education, training and future workforce / Wealth creation / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
“ Whose Shoes brings people together to have conversations that matter, the resources stimulate thoughts which lead to new insights & importantly to actions through the power of human connection & the use of narrative. ..... The energy generated is tangible .......it’s sustained long after as the creativity of both the public and professionals in unleashed. I’d really recommend the approach as a vehicle for any service committed to ongoing improvement
#Hellomynameis… Kath Evans, Experience of Care Lead (Maternity, Infants, Children and Young People), NHS England
 
“ ‘Whose Shoes’ has been an incredible catalyst in Maternity care. Having set up 5 pilot workshops with the London maternity strategic clinical network there has been a tremendous ripple out to hold further workshops in other Trusts as well as the phenomenal change platform that is #MatExp.
The actions are far to numerous to list here, some examples: a  graffiti board …to give live feedback on services, decorating the maternity theatre ceilings to improve the environment for women undergoing Caesarean section (CS), optimal cord clamping ……. midwifery workshop to explore better collaborative working - the list is endless.
We have also used ‘Whose shoes’ in other areas of the hospital with success #KHFTWhoseshoes, improving  staff attitude & environment and patient experience in our main operating theatres & having a drop in session on administration at our Trust Open Day”.

Florence Wilcock, Consultant Obstetrician Kingston Hospital NHS Foundation Trust, Chair of the London Maternity Strategic Clinical Network maternity experience subgroup.
 
"Whose Shoes is a creative opportunity to engage staff, women and patients in a process of improvement and enlightenmen, The #MatExp social movement for change ... used in our failing maternity service to better understand the experiences of women, their birth partners & our staff.  The creative energy & ideas generated during our session were directly developed into practical actions & we have subsequently used the model of engagement in other clinical areas.  Whose Shoes played an important part in our improvement journey & is having a direct impact on outcomes for women, birth partners and staff"
At the time of engaging with Whose Shoes, Steve Hams ex-Interim Dir. of Clinical Governance & Chief Nurse for the Health and Social Services Department at the States of Guernsey, now Interim Dir. of Clinical Performance & Delivery, NHS Surrey Downs CCG
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
It feels currently as though the West Midlands is largely missing out on what is now a popular, proven improvement methodology being adopted rapidly in other parts of the UK and now reaching out internationally. This tool is very different from the ‘same old’ , traditional ‘top-down’ consultation models. It is about real staff and patient engagement leading to rapid improvements – and people find it fun too!

The NHS benefits would be similar to other parts of the country but it would be easier and cheaper (travel, accommodation) to work in partnership with West Midlands (ie local) NHS Trusts / CCGs.

Also New Possibilities, the recommended graphic facilitators, with whom we work as very close business associates, are based in Birmingham.

Thus greater adoption in addition to helping, patients and helcare providers it would also allow our regionally based company to grow and develop new specialised products as well exporting this delivery process overseas e.g Currently exploring taking 'Whose Shoes Maternity' approach to Uganda.

Currently Adopted / Procured by:
  • NHS England: North region; East Midlands
  • Hospital Trusts include:
    • Kingston, Guy’s and St Thomas’s, Lewisham & Greenwich, King’s College, UCLH, Leeds, Croydon, Maidstone & Tunbridge Wells, Stockport, Manchester, NHS Cumbria, North Cumbria
  • Cheshire & Wirrall Partnership Trust
  • Guernsey HSSD
  • Great Ormond Street (partnership - CYPMeFirst masterclasses)
  • CCGs include: West Leicester, West Kent, Leeds
  • AHSN / Area Team: Wessex, Thames Valley
  • International workshops and talks delivered: Australia, Malta, France; Puerto Rico

See: www.nutshellcomms.co.uk for 'Case Studies' and other information.
Current and planned activity: 
  • Building on 5 pilot workshops (& Train the Facilitator session) carried out with NHS Eng. & the London Strategic Clinical Network supporting the new maternity experience; now spreading to hospital trusts across the UK
  • 12 Whose Shoes #dementiachallengers in March 2016 workshops across Kent, Surrey and Sussex, run by Age UK consortium, commissioned by HEEKSS
  • On-going partnership with Great Ormond Street Hospital to use bespoke scenarios in #CYPMeFirst masterclasses for multi-disciplinary health professionals working in paediatric services from many hospitals; the first 20 ‘Communications Champions, who are taking this into their own organisations; more being recruited (up to 100)  
Required activity
  • Procurement / Adoption of Whose Shoes? -  Across the W Midlands NHS Trusts, via workshops or via purchase of online/board game versions of Whose Shoes?
  • Collaborative work to personalise Whose Shoes? For particular projects or departments
What is the intellectual property status of your innovation?:
Design registered. UK Registration Design No. 4009563; Trade Mark (Whose Shoes): No. 2502651
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
Simple
Read more
Hide details
Gill Phillips 29/02/2016 - 17:31 Publish Login or Register to post comments
5
2
Votes
-99999
Innovation 'Elevator Pitch':
Proven in practice with NHS Pathology Laboratories, Pathology Manager delivers complete document management  support for all pathology process and works in partnership with any existing LIMS, PAS or Order Comms systems.
Overview of Innovation:
Complete Document Management for Pathology Departments to enable access too, and the sharing of information.
A proven scanning, barcode recognition and metadata tagging system for all paper forms used across a Pathology Department with instant retrieval & viewing from a web browser and via integration with any existing Pathology LIMS plus additional options for incorporating all other paper and digitally generated documents.
Developed in collaboration with NHS Pathology Laboratories, Pathology Manager delivers complete document management support for the whole pathology process. It enables the scanning of pathology request forms & paper documents and ingestion of digital files all into one system with intelligent barcode recognition and easy application of metadata plus instant search, retrieval & viewing directly over the organisation's network and from within an existing LIMS or PAS. It is 'plug & play' and very (very) affordable.

Uniquely with Pathology Manager, all documents - scanned paper, digitally generated (e.g. Word), emails, data reports, etc - are seen together via a Single Unified View (simultaneous viewing whatever their file type). And with instant searching, filtering and reporting plus automated alerting, auditing and monitoring, full document management across all pathology activities is ensured.

Pathology Manager works in partnership with existing LIMS (Laboratory Information Management Systems) like Clinisys MasterLab or Winpath, StarLIMS and Telepath (and any PAS) in support of all the pathology processes.

For additional information on features and benefits - Please visit:
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Advanced diagnostics, genomics and precision medicine / Wealth creation / Digital health / Innovation and adoption / Patient and medicines safety
Benefit to NHS:
Helping Pathology save costs
  • There is no limit to the number or volume of scans generated (i.e. there is no extra 'cost per image' as with most other scanning software)
  • There is no limit on the number of users
  • There is no limit to the volume of documents made available for search & retrieval
  • Instantly reduces paper storage space and improves process efficiency
  • Pathology Manager is significantly more affordable than any alternative whilst providing 'best of breed' features & functionality
Essentially, with Pathology Manager both the Cost of Purchase and the Cost of Ownership are significantly better than any alternative 

"Pathology Manager has allowed us to improve the efficiency, accuracy and speed of some of the key services provided by the Pathology Department.  It has provided a highly cost effective, high performance solution to a long standing information management challenge".   
Worcestershire NHS Pathology


For additional information on features and benefits - Please visit:
Initial Review Rating
4.20 (1 ratings)
Benefit to WM population:
  • Folding Space would like to extend the use of our software across the whole of the West Midlands as this would allow us to grow and develop not only our service here in the region but also to excelerate our software development and its facilities, products and our company.
Current and planned activity: 
  • Currently selling Pathology Manager into the NHS with adoption of the product within two trust within the West Midlands region
    • Walsall Healthcare NHS Trust
    • Worcester Health and Care NHS Trust
    • North Midlands NHS
       
  • Folding Space is working in conjunction with multiple trusts to pilot and develop a new product that will be market ready in April 2016. This project has been funded by Innovate UK
Planned / required activity
  • Increased procurement / adoption of Pathology Manager within the West Midlands region
     
  • Folding Space currently have another medical product in development that will be ready for commercialisation in April, further support and interest in the product will be sought at that time
What is the intellectual property status of your innovation?:
Folding Space owns all its IPR
Return on Investment (£ Value): 
high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
Simple
Regional Scalability:

Yes

Measures:

Revenues

Adoption target:

UK wide, commercial and public sector

Read more
Hide details
Chris Massey 29/02/2016 - 15:37 Detailed Submission Login or Register to post comments
3.3
3
Votes
-99999
Innovation 'Elevator Pitch':

UD is a unified communication platform, available across all key device types, built for efficient collaboration by health professionals. Features: powerful Group and Individual messaging, calendaring, mail, voice & audio calling and secure storage

Overview of Innovation:

See www.uniquedoc.com

Key features:

  • Confidential text chat
  • Audio - call up to 5 separate participants
  • Video calls over Wi-Fi or suitable wireless connections (reducing call costs)
  • InMail
  • Upload, Share and view images and files from encrypted Secure Storage
  • Create local specialist groups with healthcare professionals, agencies, patients or suppliers
  • Schedule events for individuals or groups
  • Email alerts updating you on new messages and events
  • Powerful Search function across all communication types

 
UNIQUEDOC is an intuitive, visually engaging unified communications platform. Borrowing familiar stylings from social media, it’s ease of use encourages focus on improving care and effective workplace collaboration, while reducing training requirements.
Confidential Chat and InMail Messaging combine with Audio and Video Calling options for effective communication while users can Store, Share and Access Files securely. As well as messaging, users can create unlimited and specialist groups, schedule Calendar Events with individuals or groups. There are Automated Message and Event alerts to keep your work on track while your corporate communications will benefit from secure broadcasted News updates to all users.
UNIQUEDOC means easy access to your communications, with ubiquitous availability; all major web browsers are supported as well as applications being available for iOS App (iOS8 and up) and Android (4.4 and up) through their app stores. UNIQUEDOC enables secure employee device usage (BYOD) in the work place.
UNIQUEDOC comes with a range of Secure Storage capacities, and a large 1GB file upload size. File Sharing is simplified and is not via local devices for improved security, while the interface features an auditable file sharing trail. The unique UNIQUEDOC Secure Vault gives you exclusive control of the most important documents.
UNIQUEDOC ends the frustration and inefficiency of multiple messaging softwares. Search all your files, communications and storage from a single, powerful engine.
UNIQUEDOC can support you with online help, tips and tutorials as well as 365/24 SLA and in-house Technical Support. We use a clustered, scalable, resilient architecture to ensure your data and communications are perfectly secure. UNIQUEDOC is fully Data Protection Act Compliant.
We have a simple business model, with a low, fixed cost implementation per user. You can also have unlimited free accounts for partners/patients.

Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Education, training and future workforce / Digital health / Innovation and adoption / Person centred care
Benefit to NHS:

Specific benefits would depend very much on the installation; the UNIQUEDOC Platform is very flexible in its deployment. In general:

  1. Low barriers to use means very low training requirements; we use familiar social media styles
  2. Fast collabortaion across teams and departments; UNIQUEDOC is great for when different departments (or even different services) that have incompatible existing systems need to work together
  3. Effective collaboration produces patient centric care
  4. Users can share documents, images and video securely with a large upload size, making video consultations a real possibility
  5. A single searchable app that can replace Skype, Dropbox, Windows Messenger etc reduces lost documents, increases security, reduces instances of communication app mis-match between staff
  6. Available across major browsers, Android and iOS (mobile and tablet), enables staff to use their own familiar, existing Smart device; reducing training time, device overheads etc
  7. VOIP calls and internet video calling reduce telephone calls costs between departments
  8. Reduced cloud storage costs through centralisation
  9. Excellent for public communication; free accounts (with access restrictions) can be used by patients
  10. Video Ad feature enables public awareness of key health issues
  11. UNIQUEDOC can be implemented without integration into other systems
  12. UNIQUEDOC can be deployed flexibly; on NHS servers, cloud services, UD servers dpending on requirements
Initial Review Rating
3.60 (2 ratings)
Benefit to WM population:

Key areas outlined in the Five Year Forward View that UNIQUEDOC can address are as follows:

  • Partnerships with local communities, local authorities, and employers
  • Employee Health
  • Patient control of health; carer support
  • Reduce barriers and increase co-operation between family Doctors, hospitals, health and social care
  • MCPs are multi discipline and will need to work together
Current and planned activity: 

We are engaging with NHS England (Tracey Grainger and team) and pursuing CCGs to undertake working trials. There is trial activity underway now with NHS Scotland/West Lothian. Meanwhile we are engaging with other digital companies already working with the NHS to expand our offering via strategic partnerships. UNIQUEDOC excells in scenarios where multiple departments need to work together so we are pursuing areas such as Health and Social Justice as well as Health and Social Care. We are reaching out to the Patient & Information Directorate through the four regional Heads of Digital Technology

What is the intellectual property status of your innovation?:

UNIQUEDOC is entirely privately owned and funded by a consortium of investors. IP Rights registration underway.
 

Return on Investment (£ Value): 
medium
Return on Investment (Timescale): 
0-6 mon
Ease of scalability: 
Simple
Read more
Hide details
Warren Carley 18/02/2016 - 22:31 Publish Login or Register to post comments
2.5
2
Votes
-99999
Innovation 'Elevator Pitch':
TeleTracking provides solutions and services that enable the highest quality of care delivery and coordination, driving access, throughput and flow from the community to the acute setting to post-acute care.
Overview of Innovation:
TeleTracking equips healthcare organisations and care providers with the IT and innovation tools needed to coordinate care across the patient’s journey. Our operational platform and services combine proprietary technology with deep domain knowledge on patient flow and healthcare operations to drive access, capacity and flow from the community to the acute setting to post-acute care. 

Through a centralised coordination centre model, TeleTracking’s IQTM Platform provides real-time visibility across networks of care, ensuring patients are cared for in the right place at the right time with the right resources. 

By providing healthcare organisations with functional and technology-driven capabilities, hospitals are able to utilise real-time and historical data for continual operational improvement and organisation intelligence, leading to a better quality of care. 
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Wealth creation / Digital health / Innovation and adoption / Patient and medicines safety / Person centred care
Benefit to NHS:
Benefits of an Organisation-Wide Coordination Centre: https://www.youtube.com/watch?v=M-bQhLmoi2A&feature=youtu.be
With TeleTracking’s IQ Platform, efficiency starts with a centralised coordination centre that creates transparency across care networks to enable precision patient placement from the community to the acute setting to post-acute care. Effectively providing the right bed, the first time, every time.

Often referred to as a ‘Mission Control’ Centre, an operational management platform provides a motion picture for healthcare organisations with real-time visibility to patients, beds, assets and staff across the care network. 

Areas of Impact
1. Access: Admissions, transfer and referrals, surgical case growth, left without being seen, A&E diversions, patient pull times
2. Throughput and Flow: Auto-discharge efficiency, patient pull times, A&E and recovery hold times, admissions, discharges per bed, utilisation rates
3. Care Support & Logistics: A&E wait times, patient and caregiver interaction, better patient experience, communication of infection status
4. Labour Productivity: Care support performance, nursing time at bedside, housekeeping performance, portering efficiency
 
Initial Review Rating
3.40 (1 ratings)
Benefit to WM population:
TeleTracking's platform would improve patient access to care in the WM region. The WM population would get access to safe and high quality care through reduction in A&E wait times, elective cancellations, and lenght of stay.
Current and planned activity: 
TeleTracking works with over 27 NHS trusts and private healthcare organisaitons in the United Kingdom to improve quality of care through improved access, throughput and flow. Lord Carter’s report “Operational productivity and performance in English NHS acute hospitals: Unwarranted variations,” found vast inefficiencies across the NHS, with particular focus on staff productivity, poor patient flow and lost bed capacity due to bed-blocking. TeleTracking’s operational platform, under the SafeHands programme at The Royal Wolverhampton Hospitals NHS Trust, was featured in the report on page 63 to highlight the use of technology to enable operational efficiencies.
What is the intellectual property status of your innovation?:
Founded in 1991, TeleTracking Technologies has developed proprietary tools to automate healthcare operations and patient flow. 
Return on Investment (£ Value): 
Very high
Return on Investment (Timescale): 
6-12 mon
Ease of scalability: 
Simple
Regulatory Approvals:
Please describe any current regulatory approvals you have achieved and how they were met/ in progress/planned.
Commercial information:
Please describe how the product/service is being developed commercially, whether in development, trials, pilot or full commercial delivery. Include the results you have from any market/demand surveys and forecasts . Please include any research you have on the broader commercial opportunity for the innovation both within the health sector nationally and internationally.
Investment activity:
Please describe what stage of investment you have reached and whether you are seeking additional rounds of investment. Please include cash investment as well as investment of soft assets such as access to specialist equipment, knowledge, trial base etc. and indicate the types/sources of your investment such as grants etc.
Regional Scalability:
Please describe how the innovation could be scaled across the WM region. Have you implemented at scale in any other regions?
Measures:
What outcomes are you hoping to achieve and what are the measures that you will use to gauge the success of the innovation and how will these assessments be made? Please ensure that you have quality, safety, cost and people measures.
Adoption target:
What are the targets for adoption across the WM and what are the minimum viability levels?
Investment sought:
What investment are you looking for in order to support wider adoption of this innovation and what have you managed to secure to date? Please provide a breakdown of these costs if possible.
Read more
Hide details
Gabrielle Zamagias 16/02/2016 - 15:56 Publish Login or Register to post comments
3
1
Votes
-99999
Innovation 'Elevator Pitch':
Virtual Clinic is an innovative mobile app which securely sends real time patient data to the hospital database.  A web interface allows the consultant to review a patient’s condition online and give feedback to the patient.
Overview of Innovation:
Virtual Clinic enables patients to manage their conditions more effectively by communicating information about their condition on a daily basis, reducing the need to attend a clinic unless it’s absolutely necessary.



A collaboration between Imobisoft and Birmingham Children’s Hospital, the Virtual Clinic app enables patients to securely communicate information about their condition directly to a clinician while simultaneously updating the Trust’s electronic patient record system.

Currently, patients with long term conditions or requiring post-operative care regularly attend outpatient clinics. The majority of these appointments require no clinical intervention and may require several hours’ travel for what might be a very brief questionnaire-based session with a clinician.
 
If a patient’s condition changes between routine appointments, the app automatically alerts the clinician who can respond immediately and effectively, having been provided with details about the change. An intervention can be made earlier, potentially decreasing the risk of morbidity or the need for more complex interventions or hospital admission.
 
Providing patients with immediate feedback on how their lifestyle or treatment impacts on their symptoms provides immediate personalised education to help them manage their condition.
 
Virtual Clinic is a free app. Users download it onto their phone and enter their unique code to create their profile. Symptoms are recorded via slider bars and radio buttons and sent in real time to the server. Clinicians view the data received, either via an alert when abnormal data is received or by logging onto the web interface to see all data for a particular patient over a period of time. Clinicians can send a message via the web interface to the patient’s phone and run reports on patients, symptoms, etc. from the database.
 
The functionality of the app can be applied to the majority of long term conditions currently managed by regular Outpatient appointments.
Stage of Development:
Market ready and adopted - Fully proven, commercially deployable, market ready and already adopted in some areas (in a different region or sector)
WMAHSN priorities and themes addressed: 
Long term conditions: a whole system, person-centred approach / Digital health
Benefit to NHS:
Successful implementation of the Virtual Clinic app will support the health care community vision and aims by:
 
1. Adding to the communication channels between patient and consultant at the time that their chronic condition has worsened
2. Improving efficiency in clinical workflows via automatic two-way messaging between the patient’s app and the clinician
3. Providing real time clinical intelligence on a patient’s symptoms to highlight any clinical issues via alerts
4. Patients using Virtual Clinic will not have to attend regular Outpatient appointments if the condition has abated, thereby freeing up Outpatient appointment slots
5. Providing prospective data on patient outcomes, informing future patient management decisions and advances in practice.
 
The implementation of Virtual Clinic is expected to realise improvements in a number of areas:
 
• Redesigned processes associated with monitoring of chronic conditions
• Real-time monitoring when a patient’s condition worsens
• Ability to interact with a patient when their condition initially worsens, rather than at an outpatient appointment when the condition has continued to deteriorate
• Decreased Outpatient appointments
• Decreased A&E attendances and admissions with disease complications
• Improvements in information for reporting purposes via the collection of data regarding a patient’s condition
• Collection of validated prospective health status data
• Improved outcome data for audit and research
• Improved patient satisfaction.

Virtual Clinic can be customised for various metrics monitored via Outpatient appointments (e.g. incontinence, asthma, diabetes, etc.). Currently, Virtual Clinic is used for patients at Birmingham Children’s Hospital with anorectic malformations and chronic constipation.

“Virtual Clinic allows the clinician to communicate via the app with the patient and give feedback. It also allows the clinician to tailor the treatment of the patient more precisely based on his daily symptom recording and therefore adjust his follow-up in clinic according his clinical needs. By allowing the clinician to monitor a patient's condition in real time, the Virtual Clinic app has huge potential to improve patient care. I believe it will reduce the number of unnecessary Outpatient appointments, deliver significant cost savings, free up capacity and inform future advances in practice."    Mr Ingo Jester, Consultant Paediatric Surgeon, Birmingham Children’s Hospital
Initial Review Rating
5.00 (1 ratings)
Benefit to WM population:
1. Imobisoft Ltd is a West Midlands based SME and adoption of the Virtual Clinic app within the region would allow the company to grow and take on additional specialist staff
2. Reduction in unnecessary Outpatient appointments
3. Improved health and wellbeing from the enablement of early intervention, potentially decreasing morbidity and preventing the need for more complex interventions or a hospital admission
4. Reduction in travel for patients (reduces pressure on the region’s transport infrastructure)
5. Reduction in the need for parents and/or carers to take time off work to escort the patient to and from hospital.
Current and planned activity: 
A pilot study is currently in progress at Birmingham Children's Hospital NHS Foundation Trust. The ROI will be available when this completed.

Other NHS engagements include:

University Hospitals of North Midlands NHS Trust
Heart of England NHS Foundation Trust
South London and Maudsley NHS Foundation Trust
What is the intellectual property status of your innovation?:
The intellectual property in the Virtual Clinic app is owned by Imobisoft Ltd.
Return on Investment (£ Value): 
N/A
Return on Investment (Timescale): 
N/A
Ease of scalability: 
4
Regulatory Approvals:
Not applicable.
Investment sought:
Not applicable.
Read more
Hide details
imobisoft 12/02/2016 - 13:47 Publish 1 comment
5
2
Votes
-99999

Active Campaigns